Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hAEC transplant in children with spastic cerebral palsy
NCT03107975Phase 1Unknown
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Apr 2017
- Primary completion
- Dec 2017
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human amniotic epithelial stem cells in spastic cerebral palsy, sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoint: Gross Motor Function Measure-66 at 6 months. Status: unknown.
02
Drugs
human amniotic epithelial stem cells
03
Conditions
spastic cerebral palsy
Beyond the preview
Go deeper on NCT03107975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107975.